Addressing Unmet Medical Needs in Type 2 Diabetes: A Narrative Review of Drugs under Development
摘要：
The global burden of type 2 diabetes is increasing worldwide, and successful treatment of this disease needs constant provision of new drugs. Twelve classes of antidiabetic drugs are currently available, and many new drugs are under clinical development. These include compounds with known mechanisms of action but unique properties, such as once-weekly DPP4 inhibitors or oral insulin. They also include drugs with new mechanisms of action, the focus of this review. Most of these compounds are in Phase 1 and 2, with only a small number having made it to Phase 3 at this time. The new drug classes described include PPAR agonists/modulators, glucokinase activators, glucagon receptor antagonists, anti-inflammatory compounds, G-protein coupled receptor agonists, gastrointestinal peptide agonists other than GLP-1, apical sodium-dependent bile acid transporter (ASBT) inhibitors, SGLT1 and dual SGLT1/SGLT2 inhibitors, and 11beta- HSD1 inhibitors.
展开
关键词：
Antidiabetic drugnew characteristic new drug development new insulin new mechanisms of action personalized medicine type 2 diabete
DOI：
10.2174/1573399810666141224121927
被引量：
年份：
2015
Semantic Scholar
(全网免费下载)
掌桥科研
万方医学
dx.doi.org
Ingenta
查看更多
NCBI
NCBI
(全网免费下载)
Europe PMC
Europe PMC
(全网免费下载)
NCBI
ResearchGate
ResearchGate
(全网免费下载)
学术范
scienceopen.com
benthamsciencepublisher.com
science-open.com
benthamscience.com
mendeley.com
benthamsciencepublishers.org
scienceopen.com
(全网免费下载)
benthamsciencepublisher.org
mysciencework.com
onAcademic
学术范
(全网免费下载)
Semantic Scholar
(全网免费下载)
NCBI
(全网免费下载)
Europe PMC
(全网免费下载)
ResearchGate
(全网免费下载)
学术范
(全网免费下载)
scienceopen.com
(全网免费下载)
通过文献互助平台发起求助，成功后即可免费获取论文全文。
相似文献
参考文献
引证文献
引用走势
站内活动
辅助模式
引用
文献可以批量引用啦~
欢迎点我试用！
